The validity of the family history method for identifying Alzheimer disease

Archives of Neurology

Volumn 54, Issue 5, 1997, Pages 634-640

  Li, Ge ^a   Aryan, Mohsen ^b,c   Silverman, Jeremy M ^b,c   Haroutunian, Vahram ^b,c   Perl, Daniel P ^e   Birstein, Sandra ^b,c   Lantz, Melinda ^d   Marin, Deborah B ^b,c   Mohs, Richard C ^b,c   Davis, Kenneth L ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Jewish Home and Hospital   (United States)

^e Veterans Affairs Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0030925314     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550170104021     Document Type: Article

References (25)

1. Heston LL, Mastri AR, Anderson VE, White J. Dementia of the Alzheimer type: clinical genetics, natural history, and associated conditions. Arch Gen Psychiatry. 1981;38:1085-1090.
2. Breitner JCS, Folstein MF. Familial Alzheimer's disease: a prevalent disorder with specific clinical features. Psychol Med. 1984;14:63-80.
3. Breitner JCS, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations. Neurology 1988;38:207-212.
4. Hirst C, Yee ML, Sadovnick AD. Familial risks of Alzheimer disease from a population-based series. Genet Epidemiol. 1994;11:365-374.
5. Korten AE, Jorm AF, Henderson AS, Broe GA, Creasey H, McCusker E. Assessing the risk of Alzheimer's disease in first-degree relatives of Alzheimer's disease cases. Psychol Med. 1993;23:915-923.
6. Silverman JM, Li G, Zaccario ML, et al. Patterns of risk in first-degree relatives of patients with Alzheimer's disease. Arch Gen Psychiatry. 1994;51:577-586.
7. Mohs RC, Breitner JCS, Silverman JM, Davis KL Alzheimer's disease: morbid risk among first-degree relatives approximates 50% by 90 years of age. Arch Gen Psychiatry. 1987;44:405-408.
8. Raiford K, Anton-Johnson S, Haycox Z, et al. CERAD, VII: accuracy of reporting dementia on death certificates of patients with Alzheimer's disease. Neurology 1994;44:2208-2209.
9. Silverman JM, Breitner JCS, Mohs RC, Davis KL. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry. 1986;143:1279-1282.
10. Silverman JM, Keefe RSE, Mohs RC, Davis KL. A study of the reliability of the family history method in genetic studies of Alzheimer's disease. Alzheimer Dis Assoc Disord. 1989;3:218-223.
11. Kawas C, Segal J, Stewart WF, Corrada M, Thai LJ. A validation study of the Dementia Questionnaire. Arch Neurol. 1994;51:901-906.
12. Thomas LD, Gonzales MF, Chamberlain A, Beyeuther K, Masters CL, Flicker L. Comparison of clinical state, retrospective informant interview and the neuropathologic diagnosis of Alzheimer's disease. Int J Geriatr Psychiatr. 1994;9:233-236.
13. Heun R, Maier W. Risk of Alzheimer's disease in first-degree relatives. Arch Gen Psychiatry. 1995;52:317-318.
14. Mendez MF, Mastri AR, Sung JH, Frey WH. Clinically diagnosed Alzheimer's disease: neuropathologic findings in 650 cases. Alzheimer Dis Assoc Disord. 1992;6:35-43.
15. Blacker D, Albert MS, Bassett SS, Go RCP, Harrell LE, Folstein MF. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease: the National Institute of Mental Health Genetics Initiative. Arch Neurol. 1994;51:1198- 1204.
16. Victoroff J, Mack WJ, Lyness SA, Chui HC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry. 1995;152:1476-1484.
17. Mirra SS, Heyman A, Mckeel D, Participating CERAD Neuropathologists, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
18. Molsa PK, Paljarvi L, Rinne JO, Rinne UK, Sako E. Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry. 1985;48:1085-1090.
19. Risse SC, Raskind MA, Nochlin D, et al. Neuropathological findings in patients with clinical diagnoses of probable Alzheimer's disease. Am J Psychiatry. 1990;147:168-172.
20. Li G, Silverman J, Altstiel L, et al. Apolipoprotein e4 allele and familial risk in Alzheimer's disease. Biol Psychiatry. 1994;35:615.
21. Gearing M, Mirra SS, Hedreen HC, Sumi SM, Hansen LA, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), X: neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology. 1995;45:461-466.
22. Klatka LA, Schiffer RB, Powers JM, Kazee AM. Incorrect diagnosis of Alzheimer's disease: a clinicopathologic study. Arch Neural. 1996;53:35-42.
23. American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatry Association; 1980.
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group Under the Auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
25. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology. 1988;38:359-364.